Solvotrin irons out global mineral deficiencies
The company has since grown rapidly, doubling from seven to 15 employees in the past year, and will expand to 20 staff members by early next year
Irish pharma company Solvotrin Therapeutics is seeking €500,000 in EIIS funding as it ramps up sales of its Active Iron supplements into international markets.
Former Ernst & Young Entrepreneur of the Year finalist Pat O’Flynn, along with pharmaceutical chemist Professor John Gilmer and clinician, entrepreneur and expert adviser to the Irish Medicines Board Dr Mark Ledwidge, established Solvotrin in 2010 as a spin-out from Trinity College Dublin and launched their first product range ...
